Home » Topics » BioWorld Science

BioWorld Science
RSS

Lundbeck updates pipeline progress of first quarter 2018

May 10, 2018

Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469

May 10, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics

May 10, 2018

IGEM Therapeutics awarded grant from Innovate UK

May 10, 2018

AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.

May 10, 2018

Novel Ironwood soluble guanylate cyclase stimulator reduces neuroinflammation

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...